sglt2 inhibitors and glp-1 receptor agonists together Combining in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique | Diabetes Therapy Updated evidence on cardiovascular and

Under him, Pfizer developed blockbusters like Eliquis and Prevnar

Heerspink HJ, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al

Regulatory oversight plays a decisive role in shaping adoption patterns, as GLP-1 injectables are regulated biologics requiring strict compliance across prescribing, dispensing, storage, and home delivery channels

Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on cardiorenal and metabolic outcomes in people without diabetes

Pfizers press release highlighted that Metsera brought four highly differentiated clinical-stage incretin and amylin programs (two injectables and two orals) to Pfizers portfolio ( [32] ) ( [11] )